NCT00751218View on ClinicalTrials.gov

A Comparative Double-Blind, Double- Dummy Study of Desloratadine (DL) 5 MG Once Daily, Cetirizine 10 MG Once Daily, and Placebo Once Daily in Patients With Chronic Idiopathic Urticaria (Study P03735)

PHASE4CompletedINTERVENTIONAL

Enrollment

174

Participants

Timeline

Start Date

May 6, 2004

Primary Completion Date

May 24, 2005

Study Completion Date

May 24, 2005

Conditions

Urticaria

Interventions

DRUG

desloratadine

desloratadine, 5mg oral tablets, once daily for 28 days

DRUG

placebo

placebo, once daily for 28 days

DRUG

cetirizine

cetirizine, 10 mg capsules once daily for 28 days

All Listed Sponsors

lead

Organon and Co

INDUSTRY

NCT00751218 - A Comparative Double-Blind, Double- Dummy Study of Desloratadine (DL) 5 MG Once Daily, Cetirizine 10 MG Once Daily, and Placebo Once Daily in Patients With Chronic Idiopathic Urticaria (Study P03735) | Biotech Hunter | Biotech Hunter